2025年のバーチャルスクリーニングのためのPubChemや他の公共データベースの活用:最新のトレンドは何ですか?
Alberto Marbán-González1, Verónica Ramírez-Cid1, Alejandro Cristóbal-Ramírez1
1DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Expert opinion on drug discovery
|September 5, 2025
まとめ
このレビューでは,PubChemのような公共データベースを 薬剤発見の仮想スクリーニングに活用する最近のトレンドを調査します. 膨大な化学空間を コンピューターで操作して 薬物の潜在的痕跡を 特定する方法を紹介しています
科学分野:
- 化学情報学
- 薬物の発見
- コンピュータ化学
背景:
- 化学情報学は,薬剤発見における大規模な化学および生物学的データセットの管理と分析に不可欠です.
- 公的データベース (PubChem,ZINC,ChEMBL,DrugBank) は,多様な化学構造と生物学的活動のための重要なリソースです.
研究 の 目的:
- 仮想スクリーニングのための公共データベースからのデータマイニングの最近の (2024-2025) 傾向をレビューする.
- 薬剤設計における実験的検証と計算ツールの統合について議論する.
- 薬の発見における広大な化学空間を 探求するための戦略を強調します
主な方法:
- SciFinderから文献を回収する
- PubChemや他の公共データベースからのデータマイニングの動向の分析
- API,類似性検索,物理化学フィルタリングを含む計算戦略のレビュー.
主要な成果:
- 効果的な計算戦略は 公共のデータベースの何十億もの化合物を 操作するのに不可欠です
- フィルタリング戦略は,評価のための集中された複合子集合の抽出を可能にします.
- 計算ツールと実験的検証の統合は,薬剤発見における情報に基づいた意思決定をサポートします.
結論:
- 公共の化学データベースは 現代の薬の発見に不可欠です
- 先進的な化学情報学ツールとフィルタリング戦略は,効率的なリード発見と最適化の鍵です.
- 計算によるアプローチと 実験による検証の連携により 薬の設計プロセスが加速します
関連する概念動画
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Ligand Binding Sites
13.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.1K
Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Protein-protein Interfaces
13.2K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.2K


